Recombinant Human Parathyroid Hormone (1-34), Shanghai Fosunpharma
注射用重组人甲状旁腺激素(1-34),上海复星生物医药研究院有限公司
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant Human Parathyroid Hormone (1-34), Shanghai Fosunpharma
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A